The role of diagnostic imaging in the assessment of liver disease continues to gain in importance. The classic techniques used for liver imaging are ultrasonography, CT and MRI. In the past decade, ...

Scientists have designed an imaging technique to detect early-stage liver tumors, and have proven it successful in mice. Their study in an animal model is an essential step toward creating tools to ...

Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...

Treating liver cancer and liver metastases — cancer that has spread to the liver from elsewhere in the body — is challenging. Most patients are not candidates for surgery because there are many tumors ...

Please provide your email address to receive an email when new articles are posted on . The American College of Radiology Liver Imaging Reporting and Data System ...

July 28 (UPI) --A new study finds that magnetic resonance imaging, or MRI, scans can be a one-stop-shop way to accurately evaluate potential living liver donors. Liver transplantation is the most ...

May 15, 2006 -- Combined contrast-enhanced magnetic resonance imaging (CCE MRI) is an accurate, noninvasive method for staging liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), ...

Please provide your email address to receive an email when new articles are posted on . Using magnetic resonance imaging, or MRI, was more accurate and effective in measuring total body iron balance ...

OXFORD, England--(BUSINESS WIRE)--Perspectum Diagnostics is excited to unveil new data at The Liver Meeting® 2019, highlighting the diagnostic capabilities of their FDA-cleared imaging products.

A new nanodiamond-based dual-mode contrast agent provides clearer and more accurate images of liver tumors at lower dosages, report researchers. Scientists from the National University of Singapore ...

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents. The new compound, called ProCA32.collagen1 ...